It looks like Virulite, a light-based device that treats cold sores from Virulite, LLC, a Costa Mesa, California company, will probably be coming to the US market.
Virulite, LLC has validated the US market for the Virulite device by successfully completing clinical trials and is presently in the process of obtaining FDA clearance. The Virulite product is successful in the UK and is both approved by the British National Health Service and CE marked.
The Virulite product, (patents granted and pending), is a portable, hand held device that uses an invisible, non-thermal band of near-infrared light. Virulite was developed in the UK after ten years of research and development, and has been medically proven in independent clinical trials to reduce the healing time of cold cores by up to one half.
The company completed a US market test of the product through Walgreen’s online distribution channel, where Virulite outsold all competing cold sore remedies, including the current market leader, the topical cream Abreva by GlaxoSmithKline (GSK).
Here’s an interesting statement from the company: “While the cold sore treatment is proven, the technology also has shown anecdotal success in treating genital herpes, bacterial infections and warts (clinical trials are underway for the latter two).”
Press release: Innovative Cold Sore Treatment Device Virulite Comes to US
Product page: Virulite Cold Sore Treatment